Company Rexahn Pharmaceuticals, Inc. Nyse
Equities
US7616401011
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,924,158 | 24,002,499 ( 92.59 %) | 0 | 92.59 % |
Company contact information
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road Suite 455
20850, Rockville
+(248) 957-9024
http://www.rexahn.com![address Rexahn Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/3064379.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.19% | 127B | |
+24.56% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-14.89% | 15.63B | |
+12.52% | 14.84B | |
-47.10% | 14.65B | |
+56.48% | 14.43B |
- Stock Market
- Equities
- Stock
- Stock
- Company Rexahn Pharmaceuticals, Inc.